Free Trial

William Blair Reiterates "Outperform" Rating for Stevanato Group (NYSE:STVN)

Stevanato Group logo with Medical background

William Blair reaffirmed their outperform rating on shares of Stevanato Group (NYSE:STVN - Free Report) in a research note released on Monday morning,RTT News reports.

Several other analysts have also recently issued reports on the company. UBS Group reduced their price objective on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a research note on Friday, March 7th. Stephens raised Stevanato Group to a "strong-buy" rating in a research report on Monday, April 21st. Two analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of €25.70 ($30.24).

Check Out Our Latest Analysis on Stevanato Group

Stevanato Group Stock Down 1.0%

Shares of STVN stock traded down €0.24 ($0.28) during trading on Monday, reaching €24.56 ($28.89). The company's stock had a trading volume of 762 shares, compared to its average volume of 336,169. Stevanato Group has a 1-year low of €17.12 ($20.14) and a 1-year high of €25.88 ($30.45). The stock's 50-day moving average price is €23.15 and its 200 day moving average price is €21.93. The company has a market capitalization of $7.44 billion, a price-to-earnings ratio of 48.16, a P/E/G ratio of 2.33 and a beta of 0.55. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.83 and a quick ratio of 1.26.

Stevanato Group Increases Dividend

The firm also recently declared an annual dividend, which will be paid on Thursday, July 17th. Shareholders of record on Thursday, June 5th will be issued a dividend of $0.0613 per share. This represents a yield of 0.3%. This is an increase from Stevanato Group's previous annual dividend of $0.05. The ex-dividend date is Thursday, June 5th.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in STVN. M&T Bank Corp acquired a new position in Stevanato Group in the fourth quarter valued at approximately $572,000. D. E. Shaw & Co. Inc. acquired a new position in shares of Stevanato Group in the 4th quarter valued at $281,000. Advantage Alpha Capital Partners LP grew its position in shares of Stevanato Group by 27.3% in the 4th quarter. Advantage Alpha Capital Partners LP now owns 293,865 shares of the company's stock valued at $6,403,000 after buying an additional 63,041 shares during the last quarter. Allianz SE acquired a new stake in Stevanato Group during the 4th quarter worth $748,000. Finally, Zions Bancorporation N.A. lifted its position in Stevanato Group by 29.7% in the fourth quarter. Zions Bancorporation N.A. now owns 68,017 shares of the company's stock valued at $1,482,000 after acquiring an additional 15,555 shares during the last quarter.

About Stevanato Group

(Get Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Read More

Analyst Recommendations for Stevanato Group (NYSE:STVN)

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in July 2025
3 Defense Stocks Under $10 With Massive Upside
NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines